Wasserman Scott M.
Insider CIK 2118767 · IKT Director · KLRA Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | A Award deriv | 2026-10-19 | 2026-10-21 | 310,000 | — | $0 | 310,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 100,000 | — | $0 | 100,000 | SEC↗ |